Metabolomics in Drug Discovery

 
Metabolomics is being used in Drug Discovery and in development from lead compound discovery to post approval drug surveillance. A consequence of disease leads to metabolic changes. These changes are the cause of disease advancement. Metabolomics can help in finding potential new sites for therapeutic intervention by identifying metabolic changes. Metabolomics can provide activity information about possible novel drugs and drug scaffolds, indicate interesting targets for drug development and suggest binding partners of compounds. Furthermore, metabolomics can be used for the discovery of novel natural products and in drug development. Metabolomics can enhance the discovery and testing of new drugs and provide insight into the on- and off-target effects of drugs. 

  • Drug metabolism during drug design and development
  • Metabolites in identification of drug targets
  • Metabonomics in preclinical pharmaceutical discovery and development
  • Toxicology and drug metabolism
  • QSAR and ligand-receptor models
  • Applications in drug development

Related Conference of Metabolomics in Drug Discovery

September 24-26, 2018

14th International Conference on Structural Biology

Berlin, Germany
October 03-04, 2018 |

4th International Conference on Biochemistry & Metabolomics

Los Angeles, California, USA
October 11-12, 2018

13th International Conference on Metabolomics and Systems Biology

Hilton Zurich Airport Hohenbuehlstrasse 10, 8152, Opfikon, Switzerland
October 18-19, 2018

10th International Congress on Structural Biology

Helsinki, Finland
November 19-20, 2018

15th World Congress on

Structural Biology

Paris, France
February 28-March 01, 2019

5th International Conference on Enzymology and Protein Chemistry

Berlin, Germany
July 31-August 01, 2019

6th International Conference on Glycobiology & Glycoproteomics

Chicago, Illinois, USA

Metabolomics in Drug Discovery Conference Speakers

Recommended Sessions

Related Journals

Are you interested in